Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hesperidin in Metabolic Syndrome
NCT00914251Phase 2Unknown
- Sponsor
- University of Rome Tor Vergata
- Start
- Nov 2008
- Primary completion
- Mar 2009
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hesperidin in metabolic syndrome, endothelial dysfunction, sponsored by University of Rome Tor Vergata. Status: unknown.
02
Drugs
hesperidin
03
Conditions
metabolic syndromeendothelial dysfunction
Beyond the preview
Go deeper on NCT00914251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914251.